Showing results (341-350 of 411) with videos related to
Sort By:
Pageof 42
Frontiers in Immunology|April 17, 2020
A Path Toward Precision Medicine for Neuroinflammatory Mechanisms in Alzheimer's DiseaseHarald Hampel, Filippo Caraci, A Claudio Cuello, et al.Neuroimage|April 6, 2016
The European DTI Study on Dementia - A multicenter DTI and MRI study on Alzheimer's disease and Mild Cognitive ImpairmentKatharina Brueggen, Michel J Grothe, Martin Dyrba, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 22, 2016
Blood-based biomarkers in Alzheimer disease: Current state of the science and a novel collaborative paradigm for advancing from discovery to clinicSid E O'Bryant, Michelle M Mielke, Robert A Rissman, et al.Neurobiology of Aging|March 3, 2024
The association between posterior resting-state EEG alpha rhythms and functional MRI connectivity in older adults with subjective memory complaintSusanna Lopez, Harald Hampel, Patrizia Andrea Chiesa, et al.Ageing Research Reviews|January 1, 2022
Toward noninvasive brain stimulation 2.0 in Alzheimer's diseaseArianna Menardi, Simone Rossi, Giacomo Koch, et al.Journal of Alzheimer'S Disease : JAD|August 17, 2013
APOE-dependent phenotypes in subjects with mild cognitive impairment converting to Alzheimer's diseaseKatrin Morgen, Lutz Frölich, Heike Tost, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 2, 2013
Designing drug trials for Alzheimer's disease: what we have learned from the release of the phase III antibody trials: a report from the EU/US/CTAD Task ForceBruno Vellas, Maria C Carrillo, Cristina Sampaio, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 12, 2014
Genetic interaction of PICALM and APOE is associated with brain atrophy and cognitive impairment in Alzheimer's diseaseKatrin Morgen, Alfredo Ramirez, Lutz Frölich, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 26, 2011
Steps to standardization and validation of hippocampal volumetry as a biomarker in clinical trials and diagnostic criterion for Alzheimer's diseaseClifford R Jack, Frederik Barkhof, Matt A Bernstein, et al.Journal of Alzheimer'S Disease : JAD|October 21, 2015
The Latent Dementia Phenotype δ is Associated with Cerebrospinal Fluid Biomarkers of Alzheimer's Disease and Predicts Conversion to Dementia in Subjects with Mild Cognitive ImpairmentAlexander Koppara, Steffen Wolfsgruber, Luca Kleineidam, et al.Pageof 42